Potential O-acyl-substituted (-)-epicatechin gallate prodrugs as inhibitors of DMBA/TPA-induced squamous cell carcinoma of skin in swiss albino mice

Chemistry and Biodiversity

Volumn 8, Issue 4, 2011, Pages 599-613

  Vyas, Sandeep ^a   Manon, Benu ^a   Vir Singh, Tej ^b   Dev Sharma, Pritam ^a   Sharma, Manu ^c  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

^c JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

Author keywords

( ) Epicatechin 3 gallate; Acylation; Antitumor activity; Bioavailability; Camellia sinensis; Green tea extract; Prodrugs

Indexed keywords

5,7 O DIACETYL 3',4' O DIACETYL 3'',4'',5'' TRIACETYLEPICATECHIN 3 O GALLATE; ANTINEOPLASTIC AGENT; DIMETHYLBENZ[A]ANTHRACENE; GREEN TEA EXTRACT; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTEIN P53; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH PH; TEA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CATECHIN; FEMALE; HUMANS; HYDROLYSIS; MICE; PRODRUGS; SKIN; SKIN NEOPLASMS; SOLUBILITY; TEA; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; CAMELLIA SINENSIS; MUS;

EID: 79954550658     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.201000219     Document Type: Article

References (46)

1. M. Kim, M. Masuda, 'Cancer Chemoprevention by Green Tea Polyphenols. Chemistry and Applications of Green Tea', CRC Press, London, 1997.
2. Y. Sadzuka, T. Sugiyama, S. Hirota, Clin. Cancer Res. 1998, 4, 153.
3. J. D. Lambert, C. S. Yang, J. Nutr. 2003, 133, 3262S.
4. J. D. Lambert, J. Hong, G. Y. Yang, J. Liao, C. S. Yang, Am. J. Clin. Nutr. 2005, 81, 284S.
5. J. V. Higdon, B. Frei, Crit. Rev. Food Sci. Nutr. 2003, 43, 89.
6. Y. Cai, N. D. Anavy, H.-H. Chow, Drug Metab. Dispos. 2002, 30, 1246.
7. H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C.-T. Ho, C. S. Yang, Drug Metab. Dispos. 2003, 31, 452.
8. H. Lu, X. Meng, C. S. Yang, Drug Metab. Dispos. 2003, 31, 572.
9. J. Rautio, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh, T. Järvinen, J. Savolainen, Nat. Rev. Drug Discovery 2008, 7, 255.
10. B. M. Liederer, R. T. Borchardt, J. Pharm. Sci. 2006, 95, 1177.
11. T. Kohri, F. Nanjo, M. Suzuki, R. Seto, N. Matsumoto, M. Yamakawa, H. Hojo, Y. Hara, D. Desai, S. Amin, C. C. Conaway, F.-L. Chung, J. Agric. Food Chem. 2001, 49, 1042.
12. W. H. Lam, A. Kazi, D. J. Kuhn, L. M. C. Chow, A. S. C. Chan, Q. P. Dou, T. H. Chan, Bioorg. Med. Chem. 2004, 12, 5587.
13. J. D. Lambert, S. Sang, J. Hong, S.-J. Kwon, M.-J. Lee, C.-T. Ho, C. S. Yang, Drug Metab. Dispos. 2006, 34, 2111.
14. B. T. Utenova, K. E. Malterud, F. Rise, ARKIVOC 2007, 9, 6.
15. S. Vyas, M. Sharma, P. D. Sharma, T. V. Singh, J. Agric. Food Chem. 2007, 55, 6319.
16. P. Chen, Y. Tan, D. Sun, X.-M. Zheng, J. Zhejiang Univ. Sci. 2003, 4, 714.
17. S. Uesato, Y. Kitagawa, Y. Hara, H. Tokuda, M. Okuda, X. Y. Mou, T. Mukainaka, H. Nishino, Bioorg. Med. Chem. Lett. 2000, 10, 1673.
18. A. Kumagai, Y. Nagaoka, T. Obayashi, Y. Terashima, H. Tokuda, Y. Hara, T. Mukainaka, H. Nishino, H. Kuwajimae, S. Uesatoa, Bioorg. Med. Chem. 2003, 11, 5143.
19. S. Uesato, T. Keisuke, A. Kumagai, Y. Nagaoka, R. Seto, Y. Hara, H. Tokuda, H. Nishino, Chem. Pharm. Bull. 2003, 51, 1448.
20. M. L. Vuotto, R. Miranda, A. Ritieni, A. Basile, L. Ricciardi, R. D. Prisco, G. Nicolosi, N. Mascolo, J. Pharm. Pharmacol. 2003, 55, 399.
21. D. J. Kuhn, W. H. Lam, A. Kazi, K. G. Daniel, S. Song, L. M. C. Chow, T. H. Chan, Q. P. Dou, Front. Biosci. 2005, 10, 1010.
22. K. R. Landis-Piwowar, D. J. Kuhn, S. B. Wan, D. Chen, T. H. Chan, Q. P. Dou, Int. J. Mol. Med. 2005, 15, 735.
23. D. M. Smith, Z. Wang, A. Kazi, L. H. Li, T. H. Chan, Q. P. Dou, Mol. Med. 2002, 8, 382.
24. N. T. Zaveri, Org. Lett. 2001, 3, 843.
25. H. Van Rensburg, P. S. Van Heerden, B. C. B. Bezuidenhoudt, D. Ferreira, Tetrahedron Lett. 1997, 38, 3089.
26. S. B. Wan, Q. P. Dou, T. H. Chan, Tetrahedron 2006, 62, 5897.
27. A. L. Lee, A. W. Liao, C. Horvath, J. Chromatogr. 1988, 443, 31.
28. M. Sharma, P. D. Sharma, M. P. Bansal, Pharm. Biol. 2007, 45, 145.
29. U. Siebenlist, G. Franzoso, K. Brown, Annu. Rev. Cell Biol. 1994, 10, 405.
30. P. Angel, A. Szabowski, M. Schorpp-Kistner, Oncogene 2001, 20, 2413.
31. E. Shaulian, M. Karin, Nat. Cell Biol. 2002, 4, 131.
32. J. Hess, P. Angel, M. Schorpp-Kistner, J. Cell Sci. 2004, 117, 5965.
33. B. B. Aggarwal, G. Sethi, A. Nair, H. Ichikawa, Curr. Signal Transduction Ther. 2006, 1, 25.
34. K. Asehnoune, D. Strassheim, S. Mitra, J.-Y. Kim, E. Abraham, J. Immunol. 2004, 172, 2522.
35. M. Asakura, M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H. Ohmoto, K. Node, K. Yoshino, H. Ishiguro, H. Asanuma, S. Sanada, Y. Matsumura, H. Takeda, S. Beppu, M. Tada, M. Hori, S. Higashiyama, Nat. Med. 2002, 8, 35.
36. M. L. Agarwal, W. R. Taylor, M. V. Chernov, O. B. Chernova, G. R. Stark, J. Biol. Chem. 1998, 273, 1.
37. M. R. Mowat, Adv. Cancer Res. 1998, 74, 25.
38. I. A. Arora, A. Siddiqui, Y. Shuklka, Mol. Cancer Ther. 2004, 3, 1459.
39. S. H. Yalkowsky, W. Morzowich, 'Drug Design', Academic press, New York, 1980.
40. H. Bundgaard, 'Design of Prodrugs', Elsevier Science Publishers, New York, 1985.
41. L. Lachman, H. A. Lieberman, J. L. Kanig, 'The Theory and Practice of Industrial Pharmacy', Varghese Publishing House, Bombay, 1987.
42. L. K. Wadhwa, P. D. Sharma, Int. J. Pharm. 1995, 118, 31.
43. M. A. Azuine, S. V. Bhide, Nutr. Cancer 1992, 17, 77.
44. D. R. Bickers, D. R. Lowy, J. Invest. Dermatol. 1989, 92, 121.
45. J. Rautio, T. Nevalainen, H. Taipale, J. Vepsäläinen, J. Gynther, K. Laine, T. Järvinen, Eur. J. Pharm. Sci. 2000, 11, 157.
46. N. M. Nielsen, H. Bundgaard, J. Med. Chem. 1989, 32, 727.